3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-Hexadecaoxapentacontane-1,50-diol

Catalog No. :
ACUYTV295
CAS No. :
351342-04-6
Molecular Formula :
C34H70O18
Molecular Weight :
766.92

IUPAC Name:3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-hexadecaoxapentacontane-1,50-diol

3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-Hexadecaoxapentacontane-1,50-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$65.00Login to see priceIn stockInquiry
250mg98%$125.00Login to see priceIn stockInquiry
1g98%$338.00Login to see priceIn stockInquiry
5g98%$1014.00Login to see priceIn stockInquiry
25g98%$3876.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-Hexadecaoxapentacontane-1,50-diol
IUPAC Name3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-hexadecaoxapentacontane-1,50-diol
MDL No.MFCD28976675
Molecular FormulaC34H70O18
Molecular Weight766.92
SMILESOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
InChI KeyNIELXDCPHZJHGM-UHFFFAOYSA-N
SynonymHO-PEG17-OH | 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-Hexadecaoxapentacontane-1,50-diol
CAS No.351342-04-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACUYTV295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUYTV295 route product structure diagram
    ACUYTV295351342-04-6 In Stock
Inquiry

2. ACUYTV295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUYTV295 route product structure diagram
    ACUYTV295351342-04-6 In Stock
Inquiry

Comments (0)